Global Vaccines Market Share to Expand at 6.32% CAGR Through 2032
According to Straits Research, the global Vaccines Market size was valued at USD 55.82 billion in 2023 and is projected to reach USD 59.34 billion in 2024 and USD 96.90 billion by 2032, growing at a CAGR of 6.32% during the forecast period (2024–2032).
Catalysts for Expansion
The Vaccines Market is witnessing substantial growth due to increasing government immunization programs, rising prevalence of infectious diseases, and advancements in biotechnology. The growing demand for mRNA vaccines, expansion of pediatric and adult immunization coverage, and research into combination vaccines are key factors driving market expansion. Additionally, increasing investments from public and private organizations in vaccine research and development (R&D) further support industry growth.
Download Free Sample Report with Complimentary Analyst Consultation : https://straitsresearch.com/report/vaccines-market/request-sample
Market Segment Breakdown
By Technology:
- Conjugate Vaccines
- Recombinant Vaccines
- Inactivated and Subunit Vaccines
- Live-Attenuated Vaccines
- Toxoid Vaccines
- Viral Vector Vaccines
- mRNA Vaccines
- Others
By Type:
- Monovalent Vaccines
- Multivalent Vaccines
By Disease Indication:
- Pneumococcal Disease
- Influenza
- Combination Vaccines
- HPV
- Meningococcal Disease
- Herpes Zoster
- Rotavirus
- MMR
- Varicella
- Hepatitis
- DTP
- Polio
- Other Disease Indications
By Route of Administration:
- Intramuscular and Subcutaneous
- Oral
- Others
By End-User:
- Pediatric Vaccine
- Adult Vaccine
Top Performing Companies
The Vaccines Market features strong competition among key players, including:
- Pfizer Inc.
- GlaxoSmithKline plc
- Merck & Co. Inc.
- Sanofi Pasteur Limited
- CSL Limited
- Emergent BioSolutions, Inc.
- Johnson & Johnson Services, Inc.
- AstraZeneca
- Astellas Pharma Inc.
- Serum Institute of India Pvt. Ltd.
- Bavarian Nordic
- Mitsubishi Tanabe Pharma Corporation
- Daiichi Sankyo Company Limited
- Panacea Biotec Ltd.
- Biological E
These companies are focused on expanding vaccine production, engaging in strategic collaborations, and launching new vaccines for emerging infectious diseases.
Emerging Prospects in the Vaccines Market
The industry is witnessing several advancements, including the rise of personalized vaccines, plant-based vaccines, and next-generation immunization technologies. The development of vaccines for non-communicable diseases, such as cancer vaccines, is also an emerging trend, broadening the scope of the market.
Industry Movements
Recent industry movements highlight increased regulatory approvals, mergers and acquisitions, and partnerships to enhance vaccine distribution. Leading manufacturers are investing in new vaccine production facilities, while governments worldwide are promoting universal immunization coverage to combat infectious diseases.
Geographic Analysis
The Vaccines Market is expanding globally, with North America and Europe leading in terms of R&D investment, vaccine approvals, and high immunization rates. The Asia-Pacific region is witnessing rapid growth due to government initiatives, population expansion, and increasing healthcare infrastructure investments. Emerging economies in Latin America and Africa are also contributing to market growth through vaccination programs supported by international health organizations.
Data Insights
Market projections suggest sustained growth driven by ongoing research, technological advancements, and expanding immunization programs. The shift toward mRNA-based vaccines and global collaborations for pandemic preparedness is expected to drive further market expansion in the coming years.
For detailed insights, contact us:
Contact Us:
Email:sales@straitsresearch.com
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
